Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.34 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.34 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | RNASEH1 | O60930 | 1/20 | 0.32 |
| ▸ | TYR | P14679 | 1/20 | 0.31 |
| ▸ | KIF11 | P52732 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22790526 | 0.74 | LMNA (0.54) | CYP2D6CYP1A2LMNATRPA1PTGS1 | |
| SCHEMBL24344763 | 0.74 | ALDH1A1 (0.41) | CYP2D6CYP1A2LMNATRPA1PTGS1 | |
| SCHEMBL17123654 | 0.72 | CYP2D6 (0.38) | CYP2D6CYP1A2LMNATRPA1PTGS1 | |
| SCHEMBL27857017 | 0.72 | CYP2D6 (0.38) | CYP2D6CYP1A2LMNATRPA1PTGS1 | |
| SCHEMBL31388034 | 0.72 | ALDH1A1 (0.57) | CYP2D6CYP1A2LMNATRPA1PTGS1 | |
| SCHEMBL13394782 | 0.72 | CYP2D6 (0.38) | CYP2D6CYP1A2LMNATRPA1PTGS1 | |
| SCHEMBL5164240 | 0.72 | ALDH1A1 (0.57) | CYP2D6CYP1A2LMNATRPA1PTGS1 | |
| SCHEMBL7635497 | 0.71 | CYP2D6 (0.37) | CYP2D6CYP1A2LMNATRPA1PTGS1 | |
| SCHEMBL25564808 | 0.71 | CYP2D6 (0.37) | CYP2D6CYP1A2LMNATRPA1PTGS1 | |
| SCHEMBL11436395 | 0.69 | LMNA (0.48) | CYP2D6CYP1A2LMNATRPA1PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220085302-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2022-03-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220085302-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | LIFR, LBR, EPOR | CYP2D6 1945/4885CYP1A2 1500/4885LMNA 2185/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.